Global Drugmakers Commit Hundreds of Billions to Expand U.S. Manufacturing
Major pharmaceutical companies are significantly expanding their manufacturing and research presence in the United States, with companies including Pfizer, Eli Lilly, Johnson & Johnson, Roche, AstraZeneca and Novartis announcing investments that together approach $500 billion. The investments cover new manufacturing facilities, research and development centers, supply-chain infrastructure and expansions of existing sites. The moves come […]
Continue Reading